Kraig Biocraft Labs CEO Outlines Commercial Scale Milestones in Spider Silk Production

Event summary

  • Kraig Biocraft Laboratories CEO Kim Thompson discussed commercial-scale production of recombinant spider silk in a Pulse 2.0 interview on June 15, 2026.
  • The company leverages an existing global silk production infrastructure, producing over 150,000 metric tons of silk annually.
  • Kraig Labs has established a world record for the largest gene insert in silkworms and engineered recombinant versions of Darwin Bark Spider silk.
  • The company aims for sustained monthly metric-ton-level production, targeting premium apparel, performance textiles, and luxury fashion markets.

The big picture

Kraig Biocraft Laboratories is positioning itself as a leader in the advanced materials industry by transforming the global silk production infrastructure with recombinant spider silk. This approach offers a sustainable and high-performance alternative to petroleum-derived synthetics, addressing growing consumer and regulatory demands for eco-friendly materials. The company's strategic expansion into Southeast Asia and technological achievements, such as the largest gene insert in silkworms, underscore its competitive advantages in the market.

What we're watching

Production Scale
How Kraig Labs will sustain monthly metric-ton-level production and integrate into existing global textile supply chains.
Market Adoption
Whether brands and manufacturers will increasingly adopt recombinant spider silk for its sustainability and performance characteristics.
Technological Leadership
The pace at which Kraig Labs can expand its intellectual property portfolio and advanced materials platform.